Monoclonal antibody-based immunotherapy for multiple myeloma

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Multiple myeloma (MM) is a fatal hematological cancer.
• Current treatments like autologous stem cell transplantation face challenges with disease recurrence.
• Allogeneic transplantation offers potential cure via donor lymphocyte immunity but is limited by graft-versus-host disease.

Purpose of the Study:

• To review multiple myeloma antigens and their corresponding antibodies.
• To explore the potential of monoclonal antibodies in MM humoral immunotherapy.

Main Methods:

• Review of scientific literature on MM antigens and antibodies.
• Analysis of preclinical data for antibody-based therapies.

Main Results:

• Monoclonal antibodies targeting MM antigens represent a promising therapeutic strategy.
• These antibodies offer a potential avenue for MM humoral immunotherapy.

Conclusions:

• Monoclonal antibodies are an attractive therapeutic tool for multiple myeloma.
• Further research into antibody-based therapies holds significant promise for improving MM treatment outcomes.